19 December 2018

[Reminder] Circular #175 Withdrawal Medical Product Containing The Active Ingredient Of Valsartan

Reference: CIR-2018-SHN0897

To all health facilities / all health care practitioners in Dubai private health sector

Please refer to Circular # 175 with details on the Withdrawal medical product containing the active ingredient of Valsartan; through the following link:


With regards - Health Regulation Sector - DHA   

Important links:

Supporting Documents:

circular 175.pdf:

View Document